Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 4, 2025 • 5:00 AM ET
As of January 4, 2025 • 5:00 AM ET
Date/Time | Source | News Release |
---|---|---|
12/23/2024 09:39 AM EST | Zacks | 5 Biotech Breakthrough Stocks to Watch in 2025 |
11/27/2024 04:31 AM EST | US Earnings Reports | Expected earnings - Ocugen, Inc. |
11/19/2024 10:10 AM EST | SeekingAlpha | Ocugen reports positive data for OCU400, OCU410 |
11/14/2024 04:40 PM EST | Zacks | Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates |
11/13/2024 04:00 PM EST | InvestorBrandNetwork | Shankar Musunuri, CEO of Ocugen Inc. (NASDAQ: OCGN), to Present at NobleCon20 |
11/08/2024 11:15 AM EST | Motley Fool | Ocugen (OCGN) Q3 2024 Earnings Call Transcript |
11/08/2024 10:18 AM EST | SeekingAlpha | Ocugen, Inc. (OCGN) Q3 2024 Earnings Call Transcript |
11/08/2024 06:55 AM EST | SeekingAlpha | Ocugen reports Q3 results |
11/07/2024 06:00 PM EST | SeekingAlpha | Here's the major earnings before the open tomorrow |
11/07/2024 11:30 AM EST | SeekingAlpha | Ocugen Q3 2024 Earnings Preview |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.